Table 1.
Clinical characteristics of 210 patients with esophageal cancer
|
Clinicopathological data
|
n
|
SHOX2 methylation
|
Septin9 methylation
|
EPO methylation
|
RNF180 methylation
|
Combined methylation detection
|
| Tumor pathology | ||||||
| Adenocarcinoma | 33 | |||||
| Squamous cell carcinoma | 177 | |||||
| P value | 0.354 | 0.19 | 0.524 | 0.098 | 0.527 | |
| Gender | ||||||
| Male | 122 | |||||
| Female | 88 | |||||
| Male vs female | 0.416 | 0.379 | 0.439 | 0.279 | 0.464 | |
| Age at diagnosis | ||||||
| ≤ 60 years | 73 | |||||
| > 60 years | 137 | |||||
| Median age (years) | 65.6 | |||||
| Mean age (years) | 63.5 | |||||
| ≤ 60 vs > 60 years | 0.665 | 0.011 | 0.021 | 0.211 | 0.001 | |
| Tumor stage | ||||||
| I-II | 19 | |||||
| III-IV | 191 | |||||
| I-II vs III-IV | 0.019 | 0.022 | 0.001 | 0.149 | 0.001 | |
| Follow-up | ||||||
| Follow-up available | 23 |